Contact
Please use this form to send email to PR contact of this press release:
Immunomic Therapeutics Announces Data Analysis of Phase IB Study to Treat Japanese Red Cedar Allergy
TO:
Dr. Bill Hearl
Immunomic Therapeutics, Inc
717-327-1919